Gustavo Baldassarre Selected Research

1-dodecylpyridoxal (PLD)

11/2016

Biomarker analysis of the MITO2 phase III trial of first-line treatment in ovarian cancer: predictive value of DNA-PK and phosphorylated ACC.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gustavo Baldassarre Research Topics

Disease

41	Neoplasms (Cancer) 01/2024 - 06/2003
22	Breast Neoplasms (Breast Cancer) 01/2024 - 04/2003
15	Ovarian Neoplasms (Ovarian Cancer) 04/2024 - 07/2003
10	Ovarian Epithelial Carcinoma 04/2024 - 07/2003
6	Neoplasm Metastasis (Metastasis) 01/2024 - 05/2008
6	Carcinoma (Carcinomatosis) 01/2019 - 04/2003
4	Carcinogenesis 06/2022 - 01/2012
4	Disease Progression 09/2021 - 12/2019
3	Inflammation (Inflammations) 01/2016 - 01/2004
3	Adenoma (Adenomas) 05/2005 - 05/2002
2	Prostatic Neoplasms (Prostate Cancer) 02/2021 - 01/2018
2	Squamous Cell Carcinoma of Head and Neck 01/2021 - 07/2017
2	Hyperplasia 01/2019 - 05/2005
2	Wounds and Injuries (Trauma) 08/2014 - 05/2014
2	Surgical Wound 05/2014 - 03/2008
2	Pituitary Neoplasms (Pituitary Adenoma) 01/2014 - 05/2002
2	Sarcoma (Soft Tissue Sarcoma) 05/2008 - 01/2005
1	Endometrial Neoplasms (Endometrial Cancer) 06/2022
1	Triple Negative Breast Neoplasms 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 10/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2021
1	Adenocarcinoma of Lung 09/2021
1	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2020
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2018
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2018
1	Genomic Instability 01/2017
1	Papilloma (Papillomatosis) 01/2012

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 10/2023 - 04/2003
13	Biomarkers (Surrogate Marker)IBA 06/2022 - 11/2011
12	PlatinumIBA 04/2024 - 01/2017
9	StathminIBA 01/2022 - 01/2005
7	MicroRNAs (MicroRNA)IBA 06/2022 - 03/2008
5	Phosphotransferases (Kinase)IBA 10/2020 - 12/2013
4	Hormones (Hormone)IBA 01/2022 - 01/2018
4	Phenobarbital (Luminal)FDA Link 01/2021 - 01/2017
3	Messenger RNA (mRNA)IBA 01/2021 - 04/2003
3	DNA (Deoxyribonucleic Acid)IBA 11/2016 - 04/2005
3	CarcinogensIBA 01/2012 - 03/2007
2	Glycine (Aminoacetic Acid)FDA LinkGeneric 11/2023 - 10/2023
2	Essential Amino AcidsIBA 11/2023 - 10/2023
2	Serine (L-Serine)FDA Link 11/2023 - 10/2023
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022 - 05/2020
2	Cyclin DIBA 01/2022 - 10/2021
2	Bevacizumab (Avastin)FDA Link 10/2021 - 05/2020
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 06/2021 - 05/2010
2	Estrogen ReceptorsIBA 06/2021 - 01/2020
2	GlucocorticoidsIBA 10/2020 - 01/2010
2	Paclitaxel (Taxol)FDA LinkGeneric 11/2016 - 02/2014
2	Ribosomal Proteins (Ribosomal Protein)IBA 01/2016 - 05/2014
2	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 01/2016 - 05/2014
2	CyclinsIBA 03/2011 - 05/2010
2	Growth Hormone (Somatotropin)IBA 05/2005 - 05/2002
1	Glycoproteins (Glycoprotein)IBA 01/2024
1	Oncogene Proteins (Oncogene Protein)IBA 10/2023
1	Amino Acids FDA Link 10/2023
1	Estrogens (Estrogen)FDA Link 06/2022
1	olaparibIBA 01/2022
1	ChromatinIBA 01/2022
1	palbociclibIBA 10/2021
1	osimertinibIBA 09/2021
1	Tyrosine Kinase InhibitorsIBA 09/2021
1	Gefitinib (Iressa)FDA Link 09/2021
1	Cell-Free Nucleic AcidsIBA 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	Cisplatin (Platino)FDA LinkGeneric 01/2021
1	Cetuximab (Erbitux)FDA Link 01/2021
1	Sp1 Transcription FactorIBA 01/2021
1	Glutamine (L-Glutamine)FDA Link 01/2020
1	LigandsIBA 01/2020
1	Epidermal Growth Factor (EGF)IBA 01/2020
1	Proline (L-Proline)FDA Link 01/2020
1	PTB-Associated Splicing FactorIBA 01/2020
1	RNA Splicing FactorsIBA 01/2020
1	human ERBB2 proteinIBA 01/2020
1	Tissue Inhibitor of Metalloproteinase-1IBA 12/2019
1	Ubiquitin-Specific ProteasesIBA 01/2019
1	Bortezomib (Velcade)FDA Link 01/2019
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2019
1	3- (4- methylphenylsulfonyl)- 2- propenenitrileIBA 01/2019
1	Proteasome InhibitorsIBA 01/2019
1	Cyclin-Dependent Kinase Inhibitor p27IBA 01/2018
1	Carboplatin (JM8)FDA LinkGeneric 11/2016
1	1-dodecylpyridoxal (PLD)IBA 11/2016
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 10/2016
1	STAT Transcription FactorsIBA 08/2014
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 08/2014
1	CytokinesIBA 08/2014
1	Indicators and Reagents (Reagents)IBA 05/2014
1	Apoptosis Regulatory ProteinsIBA 05/2014
1	Taxoids (Taxanes)IBA 02/2014
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2013
1	Tumor Viral Antigens (Large T Antigen)IBA 01/2012
1	3-methylcholanthryleneIBA 01/2012
1	Acetates (Acetic Acid Esters)FDA Link 01/2012
1	NitrosaminesIBA 01/2012
1	Cyclin D1IBA 01/2012

Therapy/Procedure

18	Therapeutics 01/2022 - 05/2008
9	Drug Therapy (Chemotherapy) 01/2022 - 01/2010
4	Radiotherapy 01/2021 - 03/2008
1	Cytoreduction Surgical Procedures 01/2022